BioCorRx Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 USD | -2.00% | -2.00% | -37.18% |
05-15 | BioCorRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | BioCorRx Inc. Announces Board Resignations | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.18% | 4.73M | |
+25.92% | 89.18B | |
-26.52% | 76.11B | |
+1.62% | 27.11B | |
-10.26% | 17.13B | |
-0.14% | 16.83B | |
+0.20% | 15.4B | |
+76.95% | 13.68B | |
+79.40% | 13.25B | |
-25.79% | 12.83B |
- Stock Market
- Equities
- BICX Stock
- News BioCorRx Inc.
- BioCorRx Inc. Auditor Raises 'Going Concern' Doubt